We’ve all heard about the marijuana growth potential in the U.S. and Canada.
However, smart investors are wise to pay attention to the international community, too.
For example, Colombia is just beginning to transform itself into a billion-dollar marijuana producer for the pharmaceutical industry. Growers estimate that the country could capture as much as one-fifth of a global market that could be worth $40 billion a year, according to Reuters.
Colombia Poised for Global Domination
Colombia is on its way to become one of the largest global export leaders in medical marijuana since legislation in the region passed in. At current pace, Colombia could supply 44% of the global demand for medical cannabis, as noted by Andres Lopez, the director of Colombia’s National Drug Fund, as quoted by Medical Marijuana Inc.
“The global cannabis market could be worth as much as US$40-billion next year, and Colombia hopes eventually to own a fifth of it; this new commodity could earn more than coffee, flower, coal or banana exports,” noted The Globe and Mail. “Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment. Colombia has the ideal climate for cannabis, with the evenly split 12 hours of light and dark each day that the plant prefers, a pool of low-cost labor and easily-transferable expertise and infrastructure from a large cut-flower export business.”
It’s quickly drawing the attention of large marijuana companies, like Canopy Growth, which just acquired Spectrum Cannabis Colombia S.A.S. for $34.8 million in stock. Canopy Latin America’s initial operations will be headquartered in Huila, Colombia, where the firm owns a 300-acre-plus farm of which more than 100 acres are licensed to produce cannabis.
The End of a Prohibition
Learn How Average Americans are Becoming Marijuana Millionaires!
Get the Full Report Here!
We can clearly see that here with Bollinger Bands set at two standard deviations above and below the 20-day moving average. Look at what happens about 80% of the time when the upper or lower Band is hit or penetrated.
MYM Nutraceuticals Inc. also just entered into an agreement to acquire a 49% stake in Colombian cannabis company, Colombia Organica, which currently holds a seed to sale license for low THC cannabis. This license permits Colombia Organica to grow, produce and create cannabis derivatives to be commercialized and / or exported.
Companies like Khiron Life Sciences are quickly expanding within the region, as well.
In fact, the Colombian-based company produces cannabis on its 2,000,000 sq. ft. facility near Bogota, Colombia and is quickly expanding its competitive advantages.
Khiron is one of the first fully licensed medical cannabis companies in the country, owner of cultivation and production licenses for both low- and high-THC, which were awarded by the Ministry of Health and Social Protection, and Ministry of Justice.
In short, don’t limit your portfolio to just the U.S. and Canada.
There’s a whole world of opportunity full of marijuana riches.
Bonus Report: Turn a Small Stake into a Fortune: A new earth-shattering government announcement could completely change the legalization of marijuana - forever. In fact, thanks to this historic legislation, tiny pot stocks trading for under $5 are getting set to double, triple, or quadruple. In an exclusive interview with Money Morning, pot stock expert Michael Robinson shares all the good news - including details on five tiny weed stocks that could potentially turn a small stake into $100,000. Click here to continue.